Date: Tue, 12 Oct 2004 00:06:49 -0400 (EDT)
From: David P. Dillard <jwne@...>
Reply-To: legalmed@yahoogroups.com
To: lawdog798@...
Cc: LegalMed Discussion Group <legalmed@yahoogroups.com>,
LegalNurse@yahoogroups.com,
medical_legal_consultants-owner@yahoogroups.com,
medical-legal-network@yahoogroups.com, MEDLEGALCONSULTANT@yahoogroups.com,
pain-in-the-law@yahoogroups.com,
Attorney-InformationExchange@yahoogroups.com,
attorney-to-expert@yahoogroups.com
Subject: Re: [LegalMed] Lisinopril - Negative Reactions

Here are some publications that may help your research regarding
Lisinopril.


Patterson CR. Davies MG. Pemphigus foliaceus:
an adverse reaction to lisinopril.
Journal of Dermatological Treatment.
15(1):60-2, 2004 Jan.


McConnell KJ. Humphries TL. Raebel MA. Merenich JA.
Clinical Pharmacy Cardiac Risk Service Study Group.
Clinical pharmacy specialist implementation of lisinopril therapy
in patients with coronary artery disease and diabetes mellitus.
Pharmacotherapy.
23(12):1564-72, 2003 Dec.


Andersen NH. Knudsen ST. Poulsen PL. Poulsen SH.
Helleberg K. Eiskjaer H. Hansen KW. Bek T. Mogensen CE.
Dual blockade with candesartan cilexetil and lisinopril in
hypertensive patients with diabetes mellitus: rationale and design.
Journal of the Renin-Angiotensin-Aldosterone System.
4(2):96-9, 2003 Jun.


Ryden L. Armstrong PW. Cleland JG. Horowitz JD. Massie BM.
Packer M. Poole-Wilson PA.
Efficacy and safety of high-dose lisinopril in chronic heart failure
patients at high cardiovascular risk, including those with
diabetes mellitus. Results from the ATLAS trial.
European Heart Journal.
21(23):1967-78, 2000 Dec.


Sorensen VB. Rossing P. Tarnow L. Parving H. Norgaard T.
Kastrup J.
Effects of nisoldipine and lisinopril on microvascular dysfunction
in hypertensive Type I diabetes patients with nephropathy.
Clinical Science.
95(6):709-17, 1998 Dec.


Chaturvedi N. Sjolie AK. Stephenson JM. Abrahamian H.
Keipes M. Castellarin A. Rogulja-Pepeonik Z. Fuller JH.
Effect of lisinopril on progression of retinopathy in normotensive
people with type 1 diabetes. The EUCLID Study Group.
EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent
Diabetes Mellitus.
Lancet.
351(9095):28-31, 1998 Jan 3.


Goa KL. Haria M. Wilde MI. Lisinopril.
A review of its pharmacology and use in the management of the
complications of diabetes mellitus.
Drugs.
53(6):1081-105, 1997 Jun.


Anonymous.
Adverse effects of lisinopril.
Lancet.
1(8635):434-5, 1989 Feb 25.


Jarvis, Blair; Spencer, Caroline M.
Management of Hypertension in Patients with Diabetes Mellitus:
Defining the Role of Lisinopril.
Disease Management & Health Outcomes.
7(5):267-288, May 2000.


Lisinopril Reduces Risk of Diabetic Retinopathy.
Clinical Diabetes.
15(4):175, July/August 1997.


Cinotti GA, Zucchelli PC, et al
Effect of lisinopril on the progression of non-diabetic
chronic renal failure
Nephrol-Dial-Transplant.
12(9):A94, 1997.


And while I have your attention, here is a resource perhaps unknown to the
members of this list that should help on many research questions.


From: "David P. Dillard" <jwne@...>
Date: Mon Oct 11, 2004 11:24 pm
Subject: Welcome Back to RedLightGreen
<http://groups.yahoo.com/group/Net-Gold/message/2157>


Sincerely,
David Dillard
Temple University
(215) 204 - 4584
jwne@...
<http://groups.yahoo.com/group/net-gold>
<http://www.edu-cyberpg.com/ringleaders/davidd.html>
<http://www.kovacs.com/medref-l/medref-l.html>
<http://listserv.temple.edu/archives/net-gold.html>
<http://www.LIFEofFlorida.org>
World Business Community Advisor
<http://www.WorldBusinessCommunity.org>


On Mon, 11 Oct 2004 lawdog798@... wrote:


> Hello All -- I have an 88 year old female client who was given Lisinopril
> after being diagnosed with a leaky valve and anemia. This was done in the
> hospital after she had been admitted for shortness of breath and hemoglobin
being
> down 50%. She had already been in the hospital for 4 or 5 days and was
> improving when this particular medication was administered. She took one dose
and
> suffered severe allergic reactions including, but not limited to, extreme
> swelling of the tongue and difficulty breathing. She was then admitted to
intensive
> care for 5 days. She is now complaining that she still has shortness of breath
> and is having difficulty walking without a cane or walker (previously did not
> need either). Furthermore, at the time that the medication was administered,
> she was a borderline diabetic. She is now diabetic.

> Did the doctor fall below the standard of care by giving her this medication
> under the above-described circumstances? My sense is that the answer is "no"
> but I would like to hear your opinions regarding the administration of
> Lisinopril and, of course, your opinions regarding the drug itself.

> Thank you!

> Lowell Steiger, Attorney at Law
> 8383 Wilshire Boulevard, Suite 830
> Beverly Hills, California 90211
> (323) 852-1100
> (323) 852-1033